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DOI 10.1186/s13756-016-0113-8RESEARCH Open AccessCross-border comparison of antibiotic
prescriptions among children and
adolescents between the north of the
Netherlands and the north-west of
Germany
Jan-Willem H. Dik1, Bhanu Sinha1, Alex W. Friedrich1*, Jerome R. Lo-Ten-Foe1, Ron Hendrix2, Robin Köck3,4,
Bert Bijker5, Maarten J. Postma5,6, Michael H. Freitag7, Gerd Glaeske8 and Falk Hoffmann7Abstract
Background: Antibiotic resistance is a worldwide problem and inappropriate prescriptions are a cause. Especially
among children, prescriptions tend to be high. It is unclear how they differ in bordering regions. This study therefore
examined the antibiotic prescription prevalence among children in primary care between northern Netherlands and
north-west of Germany.
Methods: Two datasets were used: The Dutch (IADB) comprises representative data of pharmacists in North Netherland
and the German (BARMER GEK) includes nationwide health insurance data. Both were filtered using postal codes to
define two comparable bordering regions with patients under 18 years for 2010.
Results: The proportion of primary care patients receiving at least one antibiotic was lower in northern Netherlands
(29.8 %; 95 % confidence interval [95 % CI]: 29.3–30.3), compared to north-west Germany (38.9 %; 95 % CI: 38.2–39.6).
Within the respective countries, there were variations ranging from 27.0 to 44.1 % between different areas. Most
profound was the difference in second-generation cephalosporins: for German children 25 % of the total prescriptions,
while for Dutch children it was less than 0.1 %.
Conclusions: This study is the first to compare outpatient antibiotic prescriptions among children in primary care
practices in bordering regions of two countries. Large differences were seen within and between the countries, with
overall higher prescription prevalence in Germany. Considering increasing cross-border healthcare, these comparisons
are highly valuable and help act upon antibiotic resistance in the first line of care in an international approach.
Keywords: Antibiotics, Germany, Netherlands, Border research, Health services researchBackground
Inappropriate use of antibiotics leads to significant clin-
ical and economic problems due to resistant bacteria
and increasingly limited anti-infective treatment options
[1, 2]. The majority of antibiotics are prescribed in pri-
mary care, and children receive a large portion of these* Correspondence: alex.friedrich@umcg.nl
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antibiotics are contributing to the world-wide resistance
problem [5] and promotion of appropriate use is still of
great importance [6]. Within the European Union there
are large variations in outpatient antibiotic prescriptions.
In the Netherlands, the level of prescriptions has trad-
itionally been one of the lowest in Europe. In Germany,
generally the prescription level is also relatively low [3].
However, when it comes to antibiotic prescriptions for
children and adolescents, prescriptions in Germany seem
to be higher than in other countries [7, 8]. Regardingistributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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levels than the Netherlands [9].
Due to a recent EU directive, patients can more easily
obtain health services in other European member states.
Directive 2011/24/EU creates the possibility for EU citi-
zens to cross borders and seek healthcare in another
country. This possibility for cross-border care is espe-
cially relevant for bordering regions such as the north of
the Netherlands and north-west Germany, where Dutch
healthcare centers can treat German patients and vice
versa. Considering the potential effects of inappropriate
antibiotic prescriptions in primary care, in particular
antibiotic resistance development, it is relevant to look
at differences in prescriptions between countries. It is
therefore interesting to approach the topic of antimicro-
bial therapies and their possible unwanted effects by
international cross-border collaboration, especially between
bordering regions [10]. Notably, children and adolescents
represent large group of recipients of antibiotics, in particu-
lar in outpatient care [3, 4]. The goal of this study was to
examine the prevalence and most frequently prescribed an-
tibiotics among children and adolescents in outpatient care
in adjacent Dutch and German regions, and to compare
this data. We also aimed to answer if different healthcare
systems influence prescribing or if prescribing in regions
gets more comparable the nearer they are to the border.
Methods
Study design and setting
To address the question, we chose a retrospective cross-
sectional study in a predominantly rural region including
analysis of outpatients’ data of a health insurance com-
pany and a pharmacy research database for north western
Germany (postal codes 26xxx; part of Lower Saxony) and
the northern Netherlands (postal codes 9xxx, Groningen/
Drenthe). Both regions have no major geographic and
infection risk differences, have about 1 million inhabi-
tants and share a common green border (Fig. 1). Data
comprises the year 2010 and we focused on persons
aged 0 to 18 years. Orally administered antibiotics were
selected based on the Anatomical Therapeutic Chemical
(ATC) code J01 in the outpatient setting.
Data sources
The German data including pharmacy dispensing data
come from one of the largest health insurance companies,
the BARMER GEK, representing approximately 8.4 mil-
lion persons nationwide (of them about 104,000 in postal
codes 26xxx). In total, there were 160 different statutory
health insurance companies (including BARMER GEK)
covering a total of 70 million persons (87 % of the German
population) at the end of 2010, while the remaining inhab-
itants are privately insured. The study cohort consisted of
persons who were insured at least one day in each of thefour quarters of 2010. Due to this criterion, the vast
majority of our study cohort has been continuously in-
sured throughout the whole year but infants born in
the first quarter could also be analyzed [11].
The Dutch data were derived from pharmacy dis-
pensing data of the pharmacy research database
(www.IADB.nl). The IADB comprises prescriptions de-
rived from 55 community pharmacies in the northern
part of the Netherlands and has in total approximately
600,000 persons in the database (of them about
263,000 in postal codes 9xxx). Since Dutch patients are
in general registered at one single local pharmacy in
their hometown, the chance of multiple prescriptions
of one person being counted in different areas is rela-
tively small. Registration is furthermore irrespective of
healthcare insurance and age, gender and prescription
rates among the database population have been repre-
sentative for the whole of the Netherlands [12]. Pre-
scription records are virtually complete due to the high
patient-pharmacy commitment in the Netherlands, except
for medication dispensed during hospitalization [12].
Statistical analysis
Our main outcome was outpatient prescription prevalence,
e.g. the proportion of children and adolescents receiving at
least one prescription for a systemic antibiotic in 2010.
Prevalence was stratified by sex, age groups (0–2, 3–6,
7–10, 11–13 and 14–17 years) and region of residence
(six areas for the Netherlands and nine for Germany)
alongside with 95 % confidence intervals (95 % CI).
Furthermore, the most frequently prescribed antibiotic
substances (by different ATC-codes) were studied. Stat-
istical analyses were performed with SAS, Version 9.2
(SAS Institute Inc., Cary, NC). Maps were created with
ESRI ArcGIS®, Version 10.2.2.
Results
The study cohort consisted of 36,747 children and ado-
lescents under the age of 18 years, living in the northern
Netherlands (ranging between 649–20,739 individuals per
region) and 18,374 from north-west Germany (ranging
between 988–4,028 individuals per region). For the
Netherlands, the distribution male vs. female was 50 %
vs. 50 % and for Germany 51 % vs. 49 %.
Overall, the proportion of children and adolescents re-
ceiving at least one antibiotic course in 2010 was lower in
the northern Netherlands (29.8 %; 95 % CI: 29.3–30.3)
compared to north-west Germany (38.9 %; 95 % CI: 38.2–
39.6). There were small area variations ranging from
27.0 to 36.4 % in the northern Netherlands and from
35.1 to 44.1 % in north-west Germany (Fig. 2). Prevalence
stratified by region, sex and age groups is shown in
Tables 1 and 2. The age groups with the highest propor-
tion of prescriptions were children between 0–2 years
Fig. 1 Study regions in north of the Netherlands (postal codes 9xxx; n = 36,747) and north-west Germany (postal codes 26xxx; n = 18,374)
Fig. 2 Small area variations (by postal codes) in the proportion of children and adolescents with prescriptions of antibiotics in the northern
Netherlands and north-west Germany
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Table 1 Small area variations (by postal codes) in the proportion of children and adolescents with prescriptions of antibiotics in the





95, 96 (n = 10,439) 31.6 % (30.3–32.9) 34.7 % (33.4–36.0) 33.2 % (32.3–34.1)
90, 91, 99 (n = 649) 27.7 % (23.0–32.8) 26.1 % (21.3–31.4) 27.0 % (23.6–30.6)
92, 98 (n = 1,898) 36.2 % (33.2–39.4) 36.6 % (33.5–39.8) 36.4 % (34.2–38.6)
93 (n = 868) 28.0 % (23.9–32.5) 28.0 % (23.8–32.5) 28.0 % (25.0–31.1)
94 (n = 2,154) 28.0 % (25.3–30.8) 29.2 % (26.5–31.9) 28.6 % (26.7–30.6)
97 (n = 20,739) 26.7 % (25.8–27.6) 28.9 % (28.0–29.8) 27.8 % (27.2–28.4)
Germany
261 (n = 4,028) 35.3 % (33.2–37.4) 34.9 % (32.8–37.0) 35.1 % (33.6–36.6)
262 (n = 988) 35.0 % (30.8–39.3) 42.1 % (37.6–46.6) 38.5 % (35.4–41.6)
263 (n = 1,744) 31.9 % (28.8–35.1) 38.4 % (35.2–41.7) 35.1 % (32.9–37.4)
264 (n = 1,959) 36.5 % (33.5–39.6) 34.9 % (31.8–37.9) 35.7 % (33.6–37.8)
265 (n = 1,102) 40.8 % (36.7–45.1) 41.4 % (37.2–45.6) 41.1 % (38.2–44.1)
266 (n = 2,476) 38.5 % (35.8–41.2) 40.0 % (37.2–42.8) 39.2 % (37.3–41.2)
267 (n = 1,263) 40.7 % (36.7–44.7) 43.6 % (39.8–47.5) 42.2 % (39.5–45.0)
268 (n = 3,642) 42.0 % (39.8–44.3) 46.2 % (43.9–48.6) 44.1 % (42.5–45.7)
269 (n = 1,172) 41.1 % (37.2–45.1) 40.8 % (36.7–45.0) 41.0 % (38.1–43.8)
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49.9 %) and those between 3–6 years (37.4 % vs. 54.8 %).
The proportion was considerably higher in Germany than
in the Netherlands in all age groups, for males and for
females. Males had a lower prevalence of antibiotic
prescriptions than females for both Netherlands and
Germany in all age groups, except for children aged
0–2 years old (Table 2).
Distributions of the antibiotic substances varied be-
tween the two bordering regions. Amoxicillin was the
most frequently prescribed substance in both regions,
49.6 % of all prescriptions in the Netherlands versus
21.1 % in Germany. Another profound difference was
found for second generation cephalosporins, which in
the Netherlands is reserved as a second line antibiotic.
These antibiotics comprised 25 % of the prescriptions in
Germany and less than 0.1 % in the Netherlands.
The five most frequent prescribed antibiotics for all paedi-
atric age groups covered 81.0 % of the total number of pre-
scriptions in the Netherlands vs. 64.3 % in Germany
(Table 3). In both countries, the percentage of top 5 prescrip-
tions decreased with age: in the Netherlands from 94.2 % in
0–2 year olds to 69.0 % in 14–17 year olds and in Germany
from 76.4 % in 0–2 year olds to 53.6 % in 14–17 year olds.
Discussion
Study findings and implications
This is one of the first studies to look at outpatient anti-
biotic prescriptions among children in the borderingregions of two countries. Considering the importance of
appropriate antibiotic use, the ability for patients to seek
healthcare services abroad, and the large differences be-
tween healthcare systems and guidelines, a cross-border
comparison is of great interest. Furthermore, these com-
parisons may be beneficial to inform healthcare pro-
viders and to discuss best clinical practice. We observed
considerable differences between the two countries. This
may indicate that improvements can be achieved. Mainly
on the distribution of substances, differences were profound:
second generation cephalosporins (i.e., mostly oral
cefuroxime) were prescribed in 25 % of the cases for
the German patients, while almost none of the Dutch
children received this type (<0.1 %). Given the low rate
of oral bioavailability and the high selective pressure
due to these substances, they are avoided wherever
possible in ambulatory paediatric care in the Netherlands.
It would be highly interesting and relevant to perform
further research into the reasons for prescribing second
generation cephalosporins in Germany and its long
term effects.
These differences in prescriptions of antibiotics for out-
patients between European countries have been reported
earlier, although not for bordering regions. There are
however comparisons showing differences between
Germany and the Netherlands in general [3], as well as
for children [9]. In the Netherlands, guideline adherence
is higher compared to Germany [13], which might also be
a reason for different distributions of substances between
Table 2 Proportion of children and adolescents with prescriptions of antibiotics in the northern Netherlands and north-west Germany (with 95 % CI), by sex and age group
Males Females Total
Age Netherlands (n = 18,229) Germany (n = 9,283) Netherlands (n = 18,518) Germany (n = 9,091) Netherlands (n = 36,747) Germany (n = 18,374)
0–2 years. (n = 8,075 resp. n = 1,770) 44.5 % (43.0–46.0) 53.1 % (49.8–56.4) 41.5 % (39.9–43.1) 46.6 % (43.2–50.0) 43.1 % (42.0–44.2) 49.9 % (47.6–52.3)
3–6 years. (n = 7,464 resp. n∓3,488) 35.2 % (33.8–36.8) 56.2 % (53.9–58.5) 39.9 % (38.2–41.5) 53.3 % (50.9–55.7) 37.4 % (36.3–38.5) 54.8 % (53.2–56.5)
7–10 year. (n = 6,916 resp. n = 4,292) 19.6 % (18.3–20.9) 35.4 % (33.3–37.4) 27.7 % (26.1–29.2) 37.4 % (35.4–39.5) 23.4 % (22.4–24.4) 36.4 % (35.0–37.9)
11–13 years. (n = 5,078 resp. n = 3,733) 16.3 % (14.9–17.8) 27.7 % (25.6–29.8) 19.6 % (18.0–21.2) 28.9 % (26.9–31.0) 17.9 % (16.8–18.9) 28.3 % (26.9–29.8)
14–17 years. (n = 9,214 resp. n = 5,091) 20.7 % (19.4–22.1) 29.1 % (27.4–30.9) 25.2 % (24.0–26.3) 39.1 % (37.2–41.0) 23.4 % (22.6–24.3) 34.0 % (32.7–35.3)














Table 3 The top 5 most prescribed antibiotic substances in the northern Netherlands and north-west Germany, by age group and
the total
Age Netherlands % Germany %
0–2 years.
1st Amoxicillin 70.7 % Cefaclor 29.5 %
2nd Amoxicillin-clavulanate 10.5 % Amoxicillin 22.0 %
3rd Clarithromycin 6.6 % Erythromycin 14.2 %
4th Sulfamethoxazole and trimethoprim 3.7 % Cefuroxime 5.9 %
5th Pheneticillin 2.7 % Phenoxymethylpenicillin 4.8 %
Total of the 5 most prescribed 94.2 % 76.4 %
3–6 years.
1st Amoxicillin 56.1 % Amoxicillin 22.2 %
2nd Amoxicillin-clavulanate 13.6 % Cefaclor 21.9 %
3rd Clarithromycin 8.9 % Phenoxymethylpenicillin 10.5 %
4th Pheneticillin 4.5 % Erythromycin 10.0 %
5th Sulfamethoxazole and trimethoprim 4.2 % Sulfamethoxazole and trimethoprim 7.9 %
Total of the 5 most prescribed 87.4 % 72.6 %
7–10 year.
1st Amoxicillin 43.5 % Amoxicillin 19.7 %
2nd Amoxicillin-clavulanate 13.5 % Cefaclor 18.1 %
3rd Clarithromycin 9.6 % Erythromycin 11.2 %
4th Nitrofurantoin 7.8 % Phenoxymethylpenicillin 11.1 %
5th Flucloxacillin 6.6 % Sulfamethoxazole and trimethoprim 8.1 %
Total of the 5 most prescribed 81.1 % 68.2 %
11–13 years.
1st Amoxicillin 36.5 % Amoxicillin 22.4 %
2nd Amoxicillin-clavulanate 13.2 % Cefaclor 12.6 %
3rd Clarithromycin 10.0 % Cefuroxime 10.7 %
4th Nitrofurantoin 8.9 % Sulfamethoxazole and trimethoprim 8.7 %
5th Sulfamethoxazole and trimethoprim 5.8 % Phenoxymethylpenicillin 8.1 %
Total of the 5 most prescribed 74.4 % 62.5 %
14–17 years.
1st Nitrofurantoin 19.7 % Amoxicillin 19.7 %
2nd Amoxicillin 16.0 % Cefuroxime 9.4 %
3rd Doxycycline 14.8 % Azithromycin 8.4 %
4th Amoxicillin-clavulanate 10.5 % Phenoxymethylpenicillin 8.1 %
5th Pheneticillin 8.1 % Sulfamethoxazole and trimethoprim 8.0 %
Total of the 5 most prescribed 69.0 % 53.6 %
0–17 years.
1st Amoxicillin 49.6 % Amoxicillin 21.1 %
2nd Amoxicillin-clavulanate 11.9 % Cefaclor 17.3 %
3rd Clarithromycin 7.7 % Phenoxymethylpenicillin 9.0 %
4th Nitrofurantoin 7.0 % Erythromycin 9.0 %
5th Pheneticillin 4.8 % Cefuroxime 7.9 %
Total of the 5 most prescribed 81.0 % 64.3 %
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was among the top 5 antibiotics in the Netherlands but
not in Germany. In Germany, there may still be hesitance
to prescribe nitrofurantoin due to a history of warnings
in the past (pulmonary fibrosis, neuropathy and liver
damage) [14].
In addition, the occurrence of resistant bacteria such
as MRSA differs also significantly between the bordering
regions of the Netherlands and Germany, with up to
32-fold higher MRSA incidence in the German border
region compared to the adjacent Dutch border region
[15]. In addition, higher resistance rates were also ob-
served for classical community-acquired pathogens such
as pneumococci where penicillin-resistance involved
1.9 % of invasive isolates in Germany vs. 0.2 % in the
Netherlands in 2013 [16]. The Dutch prevalence data
observed in this study are comparable to earlier studies,
indicating a quite stable use and also corroborating the
fact that the IADB database can be considered as repre-
sentative for the whole county [9, 17]. Comparing vari-
ous German studies there is a bit more variation, but it
is known that there is a quite large regional variation of
outpatient antibiotic prescriptions within the country. The
north-western part of Germany, which is included in this
study, is one of the higher prescribing regions [18, 19].
For both datasets, clinical indications for the prescrip-
tions analyzed were not known. For the Netherlands, a
large survey showed that the primary diagnosis for chil-
dren coming to general practitioners is lower respiratory
tract infections [20]. Antibiotic prescriptions by general
practitioners for children in the Netherlands are mainly for
acute otitis media and bronchitis, and especially broad-
spectrum antibiotics are still prescribed inappropriately
[21]. Dutch guidelines regarding antibiotic treatment are
very strict. Otitis media guidelines recommend antibiotics
only when there are other risk factors for complications or
with severe general symptoms [22]. For respiratory tract in-
fections, antibiotics are only recommended in the case of
pneumonia [23]. In Germany most diagnoses for children
(0–15 years) in an outpatient setting were upper respira-
tory tract infections without a focus, fever without a focus
and acute bronchitis [24]. Antibiotic prescriptions for this
group are mainly given for acute tonsillitis, bronchitis and
otitis media, for all of which appropriateness of antibiotics
is debatable [8]. The German guideline for otitis media
recommends antibiotic treatment only to be started after
two days, thereby being less conservative than the Dutch
counterpart [25]. The general guideline for bronchitis
states that when uncomplicated, antibiotics are not rec-
ommended and should be avoided [26].
Influence of parents on the prescribed antibiotic treat-
ment seems to be relatively small. A European survey,
although not performed in the Netherlands or Germany,
showed that patients tend to adhere to the decision ofthe general practitioner even when they disagree [27].
When they disagree, they have a tendency to be more con-
servative than the physician [28]. A survey in Germany
confirms this and shows that the large majority of patients
understand the limitations of antibiotic treatment for indi-
cations like the common cold [29]. The influence of the
family practitioner or paediatrician thus seems to be often
underestimated, whereas they show indeed a high inter-
individual variation in their prescription pattern [30].
Perceptions of antibiotic resistance among general practi-
tioners also differs between countries [31], probably also
leading to different prescription behaviour. A combination
of these aspects is most likely leading to the differences
between the Netherlands and Germany.
Strengths and limitations
The major strength of this study is the unique dataset of
two bordering regions coming from countries with dif-
ferent healthcare systems and antibiotic prescribing pol-
icies. Other studies compared nationwide data (either
from a subset of databases or up to 100 % coverage such
as most of ESAC). However, as shown here for the first
time, there are also large small area variations among
and between bordering regions from two different coun-
tries. Studies comparing national consumption data, ag-
gregate these data and variations within a country are
then lost, making it impossible to effectively compare
bordering regions. We were able to include about 37,000
children and adolescents living in the northern Netherlands
as well as 18,000 living in north-west Germany. However,
especially in the Netherlands our cohort size differs rele-
vantly per area (depending on the distribution of pharma-
cies included in the IADB.nl database). Therefore, in some
areas several postal codes were combined. Age distribution
and drug utilization of the patients included in the database
is, however, representative for the total Dutch population
[12]. For Germany, the sample size was somewhat smaller
than for the Netherlands. German data were derived from a
large health insurance fund and we know that differences
exist regarding socioeconomic status and morbidity be-
tween these insurance funds [32]. Such differences were
found in children and adolescents, too, but the utilization
of medications within the specific fund we used was quite
comparable to the complete German population [33].
Unfortunately, we had no access to diagnoses and indi-
cations for which antibiotics were prescribed. These
data would be relevant in determining the appropriate-
ness of the (antibiotic) treatments, and also could shed
light on the question if some patients might even be
undertreated. It seems, that coming closer to the border
increases antibiotic consumption in both countries. One
explanation might be, that these parts of the country are
furthest away from an academic centre. These (rural) parts
of the countries are also socio-economically weaker
Dik et al. Antimicrobial Resistance and Infection Control  (2016) 5:14 Page 8 of 9compared to the more densely populated parts. Such a
lower socio-economic status appears to influence anti-
biotic prescribing, although it is unclear to which extent
[34, 35]. However, more precise information is not avail-
able within the datasets used. This study should form a
starting point for (regional) antimicrobial stewardship
programs focusing on general practitioners and outpa-
tients. This group is still somewhat neglected in stew-
ardship programs, but these data show that there is a
lot to gain.
It is important to keep in mind that the structures and
organization of the two healthcare systems differ sub-
stantially between the Netherlands and Germany. In the
former, there are only family practitioners in private
practice, whereas nearly all specialists are working in
outpatient clinics in (larger) hospitals. Hence, the data
analyzed in this study primarily contain prescription data
for these family physicians. In Germany, the majority of
medical specialists, including paediatricians, is working
in private practice (or consortiums). The German data
set comprised also the data from these specialists. Previ-
ous analysis for the whole of Germany showed that 49 %
of the prescriptions came from paediatricians and 35 %
from general practitioners [19]. This may also influence
individual prescribing patterns due to a variety of reasons
and cause a bias due to more severe cases treated by spe-
cialists on the German side of the border, although we
hypothesize that severe cases are most likely send to a
hospital and are thus not included in this dataset. One
may speculate that the more individualized healthcare sys-
tem for primary care in Germany might lead to a more
heterogeneous healthcare behaviour than the more peer
group-dependent gatekeeper system in the Netherlands.
Prescribing patterns are influenced by many different
factors. Other differences between the Netherlands and
Germany (e.g. medical education, performing microbio-
logical diagnostics or healthcare insurance system) are
most likely also of influence, however to which degree is
uncertain and should be subject to further investigation.
Conclusions
Concluding, this study shows clear differences between
primary care antibiotic prescriptions for children and ad-
olescents in the bordering regions of the Netherlands
and Germany. Especially in the age group of 3–6 year-old
children, prescriptions are more frequent in Germany.
Overall there also seems to be a tendency to prescribe
broader substances in Germany compared to the
Netherlands. An evaluation like this is especially inter-
esting, considering that most antibiotics in a primary
care setting are prescribed for children. Keeping in mind
the effects that sub-optimal antibiotic treatments can
have, these comparisons of bordering regions between
two countries provide an opportunity to learn from eachother and collaborate internationally in order to counter-
act the problems of rising antibiotic resistance from a first
line of care perspective.
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